DAVIS, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. MBII, an international leader in sustainable bioprotection and plant health solutions, today announced that management has been invited to present at the MicroCap Rodeo Investment Conference in Austin, Texas on Tuesday, October 15, 2019.
Pam Marrone, CEO and Founder of Marrone Bio Innovations, will host one-on-one meetings throughout the day at The MicroCap Rodeo and is scheduled to present as follows:
The MicroCap Rodeo
Date: Tuesday, October 15, 2019
Presentation Time: 10:55am Central time
Location: Hilton Austin (500 E 4th Street, 78701 Austin, Texas)
Conference participation is by invitation only and registration is mandatory. For more information or to schedule a one-on-one meeting, please contact your conference representative.
About Marrone Bio Innovations
Marrone Bio Innovations Inc. MBII is a growth-oriented company leading the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® Jet Oxide® and Jet Ag® and Zequanox®, with a breakthrough bioherbicide and biofumigant in the Company's product pipeline. MBI also recently completed the acquisition of Pro Farm Technologies. Finland-based Pro Farm employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality.
Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Contact:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800
Email: Info@marronebio.com
Investor Relations Contact:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
MBII@mzgroup.us
www.mzgroup.us
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
